Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin with RT and Temozolomide in Glioblastoma
NCT02029573Phase 2Completed
- Sponsor
- King Fahd Medical City
- Start
- Jan 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in glioblastoma multiforme (GBM), sponsored by King Fahd Medical City. Started Jan 2014; status: completed.
02
Drugs
atorvastatin
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT02029573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02029573.